BYSI insider transaction filings
BeyondSpring Inc. — 34 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-06. Screen BYSI transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-06 | 4 | Majeti Jiangwen — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-07-06 | 4 | Qiu Min — Chief Executive Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Huang Lan — Chief Executive Officer, Director, 10% owner | Gift (G): 260,582 @ $0 | EDGAR |
| 2026-04-08 | 4 | Kirkby Matthew — Director | Grant/award (A): 23,902 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Delaney Brendan — Director | Grant/award (A): 20,427 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Majeti Jiangwen — Director | Grant/award (A): 21,730 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Lu Yingjuan June — Chief Scientific Officer | Grant/award (A): 17,840 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Huang Lan — Chief Executive Officer, Director, 10% owner | Grant/award (A): 11,514 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Xu Sihai — Director | Grant/award (A): 18,689 (derivative) @ $0 | EDGAR |
| 2026-04-03 | 4 | Fabbio Patrick — Director | Grant/award (A): 22,165 (derivative) @ $0 | EDGAR |
| 2025-10-20 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Management II (Cayman), LLC — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 85,798 @ $1.72 · Sale (S): 45,513 @ $1.76 | EDGAR |
| 2025-10-15 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Management II (Cayman), LLC — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 107,361 @ $1.70 · Sale (S): 28,495 @ $1.65 · Sale (S): 17,960 @ $1.65 | EDGAR |
| 2025-10-10 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Management II (Cayman), LLC — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 7,507 @ $1.77 · Sale (S): 3,979 @ $1.81 · Sale (S): 2,390 @ $1.77 | EDGAR |
| 2025-10-07 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Management II (Cayman), LLC — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 600 @ $1.76 · Sale (S): 17,500 @ $1.78 · Sale (S): 2,100 @ $1.79 | EDGAR |
| 2025-10-02 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Management II (Cayman), LLC — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 4,464 @ $1.81 · Sale (S): 2,601 @ $1.80 · Sale (S): 600 @ $1.73 | EDGAR |
| 2025-09-29 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 700 @ $1.66 · Sale (S): 600 @ $1.68 · Sale (S): 500 @ $1.75 | EDGAR |
| 2025-09-24 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 5,410 @ $1.83 · Sale (S): 4,106 @ $1.72 · Sale (S): 2,256 @ $1.68 | EDGAR |
| 2025-09-19 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 2,304 @ $1.83 · Sale (S): 5,307 @ $1.74 · Sale (S): 3,656 @ $1.79 | EDGAR |
| 2025-09-16 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 700 @ $1.85 · Sale (S): 2,570 @ $1.84 · Sale (S): 840 @ $1.88 | EDGAR |
| 2025-09-11 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 9,050 @ $1.97 · Sale (S): 8,176 @ $1.93 · Sale (S): 3,820 @ $1.90 | EDGAR |
| 2025-09-08 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 803 @ $1.82 · Sale (S): 1,106 @ $1.86 · Sale (S): 7,090 @ $1.93 | EDGAR |
| 2025-09-03 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 800 @ $1.74 · Sale (S): 2,800 @ $1.78 · Sale (S): 1,270 @ $1.81 | EDGAR |
| 2025-08-28 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 2,000 @ $1.79 · Sale (S): 1,300 @ $1.78 · Sale (S): 809 @ $1.81 | EDGAR |
| 2025-08-25 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 3,034 @ $1.79 · Sale (S): 2,376 @ $1.75 · Sale (S): 300 @ $1.77 | EDGAR |
| 2025-08-20 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 47,668 @ $2.03 · Sale (S): 3,604 @ $1.77 · Sale (S): 3,456 @ $1.74 | EDGAR |
| 2025-08-15 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 2,000 @ $2 · Sale (S): 2,900 @ $2 | EDGAR |
| 2025-08-11 | 4 | Decheng Capital China Life Sciences USD Fund III, L.P. — 10% owner Decheng Capital Management III (Cayman), LLC — 10% owner Decheng Capital China Life Sciences USD Fund II, L.P. — 10% owner Decheng Capital Global Healthcare Fund (Master), LP — 10% owner Decheng Capital Global Healthcare GP, LLC — 10% owner Cui Xiangmin — 10% owner | Sale (S): 5,000 @ $3.23 · Sale (S): 59,253 @ $3.17 · Sale (S): 60,000 @ $3.11 · Sale (S): 225,217 @ $3.16 · Sale (S): 1,700 @ $3.09 · Sale (S): 600 @ $2.43 · +11 more | EDGAR |
| 2025-04-23 | 4 | Kirkby Matthew — Director | Grant/award (A): 25,763 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Huang Lan — Chief Executive Officer, Director, 10% owner | Grant/award (A): 43,630 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Delaney Brendan — Director | Grant/award (A): 21,822 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Majeti Jiangwen — Director | Grant/award (A): 23,300 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Xu Sihai — Director | Grant/award (A): 19,852 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Lu Yingjuan June — Chief Scientific Officer | Grant/award (A): 18,981 (derivative) @ $0 | EDGAR |
| 2025-04-23 | 4 | Fabbio Patrick — Director | Grant/award (A): 23,793 (derivative) @ $0 | EDGAR |
Recent 8-K events — BeyondSpring Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K/A | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-15 | 8-K | 8.01 — Other Events | EDGAR |
| 2025-11-21 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-23 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=BYSI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →